Mubadala Capital
Biotech Investor · 6 portfolio companies
Portfolio
6
Combined Value
$351.1M
Focus Areas
12
Top Stage
platform
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Neumora Therapeutics | $351.1M |
| Octant Bio | — |
| Alloy Therapeutics | — |
| Novome Biotechnologies | — |
| Strateos | — |
| Sironax | — |